Naloxone methiodide
SIGMA/N129 - ≥98% (HPLC), solid
Synonym: (5α,17R)-4,5-Epoxy-3,14-dihydroxy-17-methyl-6-oxo-17-(2-propenyl)-morphinanium iodide; N-Methylnaloxonium iodide
CAS Number: 93302-47-7
Empirical Formula (Hill Notation): C20H24INO4
Molecular Weight: 469.31
MDL Number: MFCD00078592
Linear Formula: C20H24INO4
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to tan |
| drug control | regulated under CDSA - not available from Sigma-Aldrich Canada |
| form | solid |
| InChI | 1S/C20H23NO4.HI/c1-3-9-21 |
| InChI key | ICONPJDAXITIPI-UXYWFNEESA |
| Quality Level | 100 ![]() |
| SMILES string | [I-].[H][C@]12Oc3c(O)ccc4 |
| solubility | H2O: >10 mg/mL |
| storage temp. | 2-8°C |
| Application: | Naloxone methiodide has been used as inhibitor of opioid receptor in fish and mice. Naloxone methiodide has been used to block opioid neurotransmission. |
| Biochem/physiol Actions: | Naloxone methiodide has low affinity for opioid receptors than naloxone. Administration of naloxone inhibits opioid receptor and opioid-induced respiratory depression. |
| Biochem/physiol Actions: | Quaternary salt of naloxone that, like the parent compound, is a nonselective antagonist at opioid receptors. It does not cross the blood-brain barrier. |
| Packaging: | 25, 100, 250 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H315 - H319 - H335 |
| Precautionary statements | P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


